Return to homepagePandemic Pact

Characterization of biofilm formation in shigellosis

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R21AI193486-01A1

Grant search

Key facts

  • Disease

    Shigellosis
  • Start & end year

    2026
    2028
  • Known Financial Commitments (USD)

    $236,538
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    PROFESSOR HERVE AGAISSE
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF VIRGINIA
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Abstract The intestinal pathogen Shigella flexneri is the causative agent of bacillary dysentery and is responsible for more than 250 million cases of dysentery annually, resulting in more than 200,000 deaths. S. flexneri is an intracellular pathogen that invade epithelial cells in the colon and spread from cell to cell. The dissemination process relies on a bacterial adaptor termed IcsA that recruits key components of the actin cytoskeleton and supports actin-based motility. We have recently discovered that in addition of its intracellular role in dissemination, IcsA also support bile salt-dependent biofilm formation. Here, we propose to characterize the structural determinants that support IcsA-mediated bile salts-dependent biofilm formation (Aim1) and the role of IcsA in extracellular and intracellular colonization in an infant rabbit model of shigellosis (Aim2). The characterization of the dual functions of IcsA will provide novel insights into the mechanisms supporting bacillary dysentery in humans.